Kaempferol reduced glucose uptake and lactate production in drug-resistant CRC cells, and increased the expression of microRNA-326 (miR-326), which targets PKM2 and inhibits glycolysis, thereby reversing 5-FU resistance (Wu et al., 2022). Here, PKM is linked to colorectal carcinoma.